Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology
Identifieur interne : 001942 ( Main/Exploration ); précédent : 001941; suivant : 001943Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology
Auteurs : Ana F. Rodrigues [Portugal] ; Hugo R. Soares [Portugal] ; Miguel R. Guerreiro [Portugal] ; Paula M. Alves [Portugal] ; Ana S. Coroadinha [Portugal]Source :
- Biotechnology Journal [ 1860-6768 ] ; 2015-09.
Abstract
Vaccination is one of the most effective interventions in global health. The worldwide vaccination programs significantly reduced the number of deaths caused by infectious agents. A successful example was the eradication of smallpox in 1979 after two centuries of vaccination campaigns. Since the first variolation administrations until today, the knowledge on immunology has increased substantially. This knowledge combined with the introduction of cell culture and DNA recombinant technologies revolutionized vaccine design. This review will focus on vaccines against human viral pathogens, recent developments on vaccine design and cell substrates used for their manufacture. While the production of attenuated and inactivated vaccines requires the use of the respective permissible cell substrates, the production of recombinant antigens, virus‐like particles, vectored vaccines and chimeric vaccines requires the use – and often the development – of specific cell lines. Indeed, the development of novel modern viral vaccine designs combined with, the stringent safety requirements for manufacture, and the better understanding on animal cell metabolism and physiology are increasing the awareness on the importance of cell line development and engineering areas. A new era of modern vaccinology is arriving, offering an extensive toolbox to materialize novel and creative ideas in vaccine design and its manufacture.
In the past, animal cell culture and DNA recombinant technologies were decisive for vaccine progress, allowing the development of inactivated, attenuated and subunit protein based vaccines. Today, synthetic biology further expands vaccine design originating a myriad of different vaccines as chimeric ones, still under development but holding great expectations. This review focuses on vaccines against human viral pathogens, recent developments on vaccine design and cell substrates used for their manufacture. A new era of modern vaccinology is arriving, offering an extensive toolbox to materialize novel and creative ideas in vaccine design and its manufacture.
Url:
DOI: 10.1002/biot.201400387
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001484
- to stream Istex, to step Curation: 001484
- to stream Istex, to step Checkpoint: 000086
- to stream Main, to step Merge: 001947
- to stream Main, to step Curation: 001942
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology</title><author><name sortKey="Rodrigues, Ana F" sort="Rodrigues, Ana F" uniqKey="Rodrigues A" first="Ana F." last="Rodrigues">Ana F. Rodrigues</name></author><author><name sortKey="Soares, Hugo R" sort="Soares, Hugo R" uniqKey="Soares H" first="Hugo R." last="Soares">Hugo R. Soares</name></author><author><name sortKey="Guerreiro, Miguel R" sort="Guerreiro, Miguel R" uniqKey="Guerreiro M" first="Miguel R." last="Guerreiro">Miguel R. Guerreiro</name></author><author><name sortKey="Alves, Paula M" sort="Alves, Paula M" uniqKey="Alves P" first="Paula M." last="Alves">Paula M. Alves</name></author><author><name sortKey="Coroadinha, Ana S" sort="Coroadinha, Ana S" uniqKey="Coroadinha A" first="Ana S." last="Coroadinha">Ana S. Coroadinha</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:634CA7F1CBD1BBB739F4EC4C206C7B3BD5B3A994</idno><date when="2015" year="2015">2015</date><idno type="doi">10.1002/biot.201400387</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-CC0PHLNG-8/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001484</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001484</idno><idno type="wicri:Area/Istex/Curation">001484</idno><idno type="wicri:Area/Istex/Checkpoint">000086</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000086</idno><idno type="wicri:doubleKey">1860-6768:2015:Rodrigues A:viral:vaccines:and</idno><idno type="wicri:Area/Main/Merge">001947</idno><idno type="wicri:Area/Main/Curation">001942</idno><idno type="wicri:Area/Main/Exploration">001942</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology</title><author><name sortKey="Rodrigues, Ana F" sort="Rodrigues, Ana F" uniqKey="Rodrigues A" first="Ana F." last="Rodrigues">Ana F. Rodrigues</name><affiliation wicri:level="1"><country xml:lang="fr">Portugal</country><wicri:regionArea>iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras</wicri:regionArea><wicri:noRegion>Oeiras</wicri:noRegion></affiliation></author><author><name sortKey="Soares, Hugo R" sort="Soares, Hugo R" uniqKey="Soares H" first="Hugo R." last="Soares">Hugo R. Soares</name><affiliation wicri:level="1"><country xml:lang="fr">Portugal</country><wicri:regionArea>iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras</wicri:regionArea><wicri:noRegion>Oeiras</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Portugal</country><wicri:regionArea>Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras</wicri:regionArea><wicri:noRegion>Oeiras</wicri:noRegion></affiliation></author><author><name sortKey="Guerreiro, Miguel R" sort="Guerreiro, Miguel R" uniqKey="Guerreiro M" first="Miguel R." last="Guerreiro">Miguel R. Guerreiro</name><affiliation wicri:level="1"><country xml:lang="fr">Portugal</country><wicri:regionArea>iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras</wicri:regionArea><wicri:noRegion>Oeiras</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Portugal</country><wicri:regionArea>Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras</wicri:regionArea><wicri:noRegion>Oeiras</wicri:noRegion></affiliation></author><author><name sortKey="Alves, Paula M" sort="Alves, Paula M" uniqKey="Alves P" first="Paula M." last="Alves">Paula M. Alves</name><affiliation wicri:level="1"><country xml:lang="fr">Portugal</country><wicri:regionArea>iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras</wicri:regionArea><wicri:noRegion>Oeiras</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Portugal</country><wicri:regionArea>Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras</wicri:regionArea><wicri:noRegion>Oeiras</wicri:noRegion></affiliation></author><author><name sortKey="Coroadinha, Ana S" sort="Coroadinha, Ana S" uniqKey="Coroadinha A" first="Ana S." last="Coroadinha">Ana S. Coroadinha</name><affiliation wicri:level="1"><country xml:lang="fr">Portugal</country><wicri:regionArea>iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras</wicri:regionArea><wicri:noRegion>Oeiras</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Portugal</country><wicri:regionArea>Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras</wicri:regionArea><wicri:noRegion>Oeiras</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Portugal</country></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Portugal</country><wicri:regionArea>Correspondence address: Correspondence: Dr. Ana S. Coroadinha, iBET, Apartado 12, 2780‐901 Oeiras</wicri:regionArea><wicri:noRegion>2780‐901 Oeiras</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Biotechnology Journal</title><title level="j" type="alt">BIOTECHNOLOGY JOURNAL</title><idno type="ISSN">1860-6768</idno><idno type="eISSN">1860-7314</idno><imprint><biblScope unit="vol">10</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="1329">1329</biblScope><biblScope unit="page" to="1344">1344</biblScope><biblScope unit="page-count">16</biblScope><publisher>WILEY‐VCH Verlag</publisher><pubPlace>Weinheim</pubPlace><date type="published" when="2015-09">2015-09</date></imprint><idno type="ISSN">1860-6768</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1860-6768</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Vaccination is one of the most effective interventions in global health. The worldwide vaccination programs significantly reduced the number of deaths caused by infectious agents. A successful example was the eradication of smallpox in 1979 after two centuries of vaccination campaigns. Since the first variolation administrations until today, the knowledge on immunology has increased substantially. This knowledge combined with the introduction of cell culture and DNA recombinant technologies revolutionized vaccine design. This review will focus on vaccines against human viral pathogens, recent developments on vaccine design and cell substrates used for their manufacture. While the production of attenuated and inactivated vaccines requires the use of the respective permissible cell substrates, the production of recombinant antigens, virus‐like particles, vectored vaccines and chimeric vaccines requires the use – and often the development – of specific cell lines. Indeed, the development of novel modern viral vaccine designs combined with, the stringent safety requirements for manufacture, and the better understanding on animal cell metabolism and physiology are increasing the awareness on the importance of cell line development and engineering areas. A new era of modern vaccinology is arriving, offering an extensive toolbox to materialize novel and creative ideas in vaccine design and its manufacture.</div><div type="abstract" xml:lang="en">In the past, animal cell culture and DNA recombinant technologies were decisive for vaccine progress, allowing the development of inactivated, attenuated and subunit protein based vaccines. Today, synthetic biology further expands vaccine design originating a myriad of different vaccines as chimeric ones, still under development but holding great expectations. This review focuses on vaccines against human viral pathogens, recent developments on vaccine design and cell substrates used for their manufacture. A new era of modern vaccinology is arriving, offering an extensive toolbox to materialize novel and creative ideas in vaccine design and its manufacture.</div></front></TEI><affiliations><list><country><li>Portugal</li></country></list><tree><country name="Portugal"><noRegion><name sortKey="Rodrigues, Ana F" sort="Rodrigues, Ana F" uniqKey="Rodrigues A" first="Ana F." last="Rodrigues">Ana F. Rodrigues</name></noRegion><name sortKey="Alves, Paula M" sort="Alves, Paula M" uniqKey="Alves P" first="Paula M." last="Alves">Paula M. Alves</name><name sortKey="Alves, Paula M" sort="Alves, Paula M" uniqKey="Alves P" first="Paula M." last="Alves">Paula M. Alves</name><name sortKey="Coroadinha, Ana S" sort="Coroadinha, Ana S" uniqKey="Coroadinha A" first="Ana S." last="Coroadinha">Ana S. Coroadinha</name><name sortKey="Coroadinha, Ana S" sort="Coroadinha, Ana S" uniqKey="Coroadinha A" first="Ana S." last="Coroadinha">Ana S. Coroadinha</name><name sortKey="Coroadinha, Ana S" sort="Coroadinha, Ana S" uniqKey="Coroadinha A" first="Ana S." last="Coroadinha">Ana S. Coroadinha</name><name sortKey="Coroadinha, Ana S" sort="Coroadinha, Ana S" uniqKey="Coroadinha A" first="Ana S." last="Coroadinha">Ana S. Coroadinha</name><name sortKey="Guerreiro, Miguel R" sort="Guerreiro, Miguel R" uniqKey="Guerreiro M" first="Miguel R." last="Guerreiro">Miguel R. Guerreiro</name><name sortKey="Guerreiro, Miguel R" sort="Guerreiro, Miguel R" uniqKey="Guerreiro M" first="Miguel R." last="Guerreiro">Miguel R. Guerreiro</name><name sortKey="Soares, Hugo R" sort="Soares, Hugo R" uniqKey="Soares H" first="Hugo R." last="Soares">Hugo R. Soares</name><name sortKey="Soares, Hugo R" sort="Soares, Hugo R" uniqKey="Soares H" first="Hugo R." last="Soares">Hugo R. Soares</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001942 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001942 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:634CA7F1CBD1BBB739F4EC4C206C7B3BD5B3A994
|texte= Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology
}}
| This area was generated with Dilib version V0.6.33. |  |